We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. Nationwide epidemiologic survey on incidence of macular dystrophy in Japan

    Purpose

    The aim of this study was to estimate the number of patients in Japan who had visited an ophthalmologist for macular dystrophy of various...

    Shinji Ueno, Takaaki Hayashi, ... Mineo Kondo in Japanese Journal of Ophthalmology
    Article 03 April 2024
  2. Spontaneous Diaphragmatic Rupture in Muscular Dystrophy Misdiagnosed as Pneumothorax: a Case Report

    Diaphragmatic rupture is almost always iatrogenic with variable presentation. It should be diagnosed with high suspicion index in blunt thoracic...

    Pavan Kumar Dammalapati in SN Comprehensive Clinical Medicine
    Article 30 November 2023
  3. Fuchs endothelial corneal dystrophy: an updated review

    Purpose

    The present review will summarize FECD-associated genes and pathophysiology, diagnosis, current  therapeutic approaches, and future treatment...

    Francisco Altamirano, Gustavo Ortiz-Morales, ... Jorge E. Valdez-Garcia in International Ophthalmology
    Article 12 February 2024
  4. AChR-seropositive myasthenia gravis in muscular dystrophy: diagnostic pitfalls and clinical management challenges

    The co-occurrence of genetic myopathies with myasthenia gravis (MG) is extremely rare, however a few studies have been reported. We aim to explore...

    Anna Rosa Avallone, Vincenzo Di Stefano, ... Claudia Vinciguerra in Neurological Sciences
    Article 05 July 2024
  5. Greater cortical thinning and microstructural integrity loss in myotonic dystrophy type 1 compared to myotonic dystrophy type 2

    Background

    Myotonic dystrophy is a multisystem disorder characterized by widespread organic involvement including central nervous system symptoms....

    Britta Krieger, Christiane Schneider-Gold, ... Carsten Lukas in Journal of Neurology
    Article Open access 19 June 2024
  6. Social difficulties and care burden of adult Duchenne muscular dystrophy in Japan: a questionnaire survey based on the Japanese Registry of Muscular Dystrophy (Remudy)

    Background

    Little is known about the social difficulties and health care needs of adult Duchenne muscular dystrophy (DMD) patients in Japan, as well...

    Madoka Mori-Yoshimura, Keiko Ishigaki, ... Harumasa Nakamura in Orphanet Journal of Rare Diseases
    Article Open access 30 April 2024
  7. Cognitive abnormalities in Becker muscular dystrophy: a mysterious link between dystrophin deficiency and executive functions

    Background

    Distrophinopathies are a heterogeneous group of neuromuscular disorders due to mutations in the DMD gene. Different isoforms of dystrophin...

    Laura Pezzoni, Roberta Brusa, ... Maria Cristina Saetti in Neurological Sciences
    Article Open access 15 November 2023
  8. Early versus late diagnosis of LAMA2 congenital muscular dystrophy: a distinct consequence

    Background

    Laminin subunit alpha 2 ( LAMA2 )-related muscular dystrophy ( LAMA2 MD) is caused by homozygous or compound heterozygous mutations in LAMA2 ...

    Chien-Heng Lin, Sheng-Shing Lin, ... I-Ching Chou in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
    Article Open access 05 January 2024
  9. An early onset cone dystrophy due to CEP290 mutation: a case report

    Purpose

    Biallelic mutations in the CEP290 gene cause early onset retinal dystrophy or syndromic disease such as Senior-Loken or Joubert syndrome....

    Anastasia Binder, Susanne Kohl, ... Katarina Stingl in Documenta Ophthalmologica
    Article Open access 29 August 2023
  10. Diagnosis and management of Becker muscular dystrophy: the French guidelines

    Becker muscular dystrophy (BMD) is one of the most frequent among neuromuscular diseases, affecting approximately 1 in 18,000 male births. It is...

    Armelle Magot, Karim Wahbi, ... Ulrike Walther-Louvier in Journal of Neurology
    Article 09 July 2023
  11. Tamoxifen may contribute to preserve cardiac function in Duchenne muscular dystrophy

    Duchenne muscular dystrophy is life-limiting. Cardiomyopathy, which mostly ensues in the second decade of life, is the main cause of death. Treatment...

    Bettina C. Henzi, Sebastiano A. G. Lava, ... Dirk Fischer in European Journal of Pediatrics
    Article Open access 03 July 2024
  12. Classic lattice corneal dystrophy: a brief review and summary of treatment modalities

    Purpose

    To provide a brief summary and comparison of the most recent literature on available and theorized treatment modalities for classic lattice...

    Ekaterina Milovanova, Stanislav Gomon, Guillermo Rocha in Graefe's Archive for Clinical and Experimental Ophthalmology
    Article 07 November 2023
  13. Afterdischarges in myotonic dystrophy type 1

    Objective

    Electrodiagnostic testing is an important screening test for myotonic dystrophy type 1 (DM1). Although myotonic discharges are observed on...

    Li Yang, **uying Chen, Rui Wu in Neurological Sciences
    Article 16 August 2023
  14. Multi-level profiling unravels mitochondrial dysfunction in myotonic dystrophy type 2

    Myotonic dystrophy type 2 (DM2) is an autosomal-dominant multisystemic disease with a core manifestation of proximal muscle weakness, muscle atrophy,...

    Felix Kleefeld, Rita Horvath, ... Werner Stenzel in Acta Neuropathologica
    Article Open access 19 January 2024
  15. Duchenne muscular dystrophy: pathogenesis and promising therapies

    Duchenne muscular dystrophy (DMD) is a severe, progressive, muscle-wasting disease, characterized by progressive deterioration of skeletal muscle...

    Mengyuan Chang, Yong Cai, ... Hualin Sun in Journal of Neurology
    Article 01 June 2023
  16. Myotonic dystrophy type 1 in the COVID-19 era

    Introduction

    Myotonic dystrophy type 1 (DM1) is the most prevalent muscular dystrophy in adults. People with DM1 might represent a high-risk...

    Jelena Ilic Zivo**ovic, Katarina Djurdjevic, ... Stojan Peric in Neurological Sciences
    Article Open access 08 May 2023
  17. Does Platelet-Rich Plasma Deserve a Role in Accelerating the Recovery of Reflex Sympathetic Dystrophy Following Distal Radius Fracture?

    Introduction

    This study was to evaluate the efficacy of multiple platelet-rich plasma injections in reflex sympathetic dystrophy following distal...

    Raghavendra S. Kulkarni, SriRam R. Kulkarni, ... Ranjani R. Kulkarni in Indian Journal of Orthopaedics
    Article 17 May 2024
  18. Updates on Facioscapulohumeral Muscular Dystrophy (FSHD)

    Purpose of review

    This review aims to provide a summary of the pathophysiology, clinical presentation and management options for facioscapulohumeral...

    Amanda X. Y. Chin, Zhi Xuan Quak, ... Kay W. P. Ng in Current Treatment Options in Neurology
    Article 02 April 2024
  19. The pseudohypopyon stage in adult-onset foveomacular vitelliform dystrophy

    Purpose

    To gain insight into the pathogenesis of adult-onset foveomacular vitelliform dystrophy (AFVD) via assessment of its pseudohypopyon stage...

    Or Shmueli, Rivkah Lender, ... Liran Tiosano in International Ophthalmology
    Article 17 April 2023
  20. Presumed Bietti crystalline dystrophy with optic nerve head drusen: a case report

    Background

    Bietti crystalline dystrophy is primarily a retinal dystrophy caused by a CYP4V2 mutation and typically presents with crystalline retinal...

    Fatemeh Bazvand, Esmaeil Asadi Khameneh in Journal of Medical Case Reports
    Article Open access 02 November 2022
Did you find what you were looking for? Share feedback.